Individualised Homoeopathic medicine in centesimal potencies versus LM potencies in cases of psoriasis

Phase 2

Recruiting

• Conditions: Generalized pustular psoriasis,

• Registration Number: CTRI/2023/09/058058

Brief Summary

Psoriasis is a chronic inflammatory, hyperproliferative, skin disease.

It is characterized by well-defined erythematous,scaly plaques, itching and erythema, particularly affecting extensor surfacesand scalp, usually follows relapsing and remitting course.

According to [ETHealthWorld](https://health.economictimes.indiatimes.com/agency/88675629/ETHealthWorld) (October 31, 2022, 06:44IST), The prevalence rate of psoriasis is around 2 – 4 % in the western world,whereas in India it is around 1 -2 %. It is also alarming to note that theprevalence of the disease is increasing in developing countries also.

Hahnemann in his 6th editionof Organon of Medicine mentioned the new method of preparation ofmedicines i.e. renewed dynamization or fifty millesimal (LM) potencies whichcaused less aggravation in comparison to centesimal (CM) potencies, where thepatient had to wait as long as they were improving even in the slightest mannerafter single dose of medicine.

A analytic randomized exploratory study designed to compare the effectiveness of homoeopathic medicines in LM verses CM potencies

Detailed Description

Not available

Study Timeline

• Study Start: 2023-05-10
• Last Update Posted: 2023-11-24

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

• Pre-diagnosed or cases having clinical features of Psoriasis.
• Cases of Psoriasis seeking treatment from any other system of medicines like Allopathy, Ayurvedic, etc., will be considered after a washout period of 1 month.
• Patients seeking Homoeopathic treatment prior to the visit will also be taken into consideration after 1 month of washout period.
• Adult age group 18 years to 65 years.
• The patients giving their consent to participate in study with six follow ups.

Exclusion Criteria

• The psoriasis cases with other comorbidities.
• Participants with other co-existing skin conditions.
• Pregnant and Lactating mother.
• The case without proper follow-up and discontinuation of treatment in between the study will be dropped out.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To compare individualised homoeopathic medicine in centesimal potencies versus LM potencies the management of psoriasis.	3rd Month, 6th month

Secondary Outcome Measures

Name	Time	Method
To clinically assess treatment outcome in cases of psoriasis using Psoriasis Area & Severity Index (PASI)
To study the role individualised homoeopathic medicine in psoriasis	6 Months

Trial Locations

Locations (1)

Jawaharlal Nehru Homoeopathic Medical College and Hospital,Parul University; 🇮🇳 Vadodara, GUJARAT, India

Jawaharlal Nehru Homoeopathic Medical College and Hospital,Parul University

🇮🇳Vadodara, GUJARAT, India

Dr Amit Nayak

Principal investigator

8141598111

amit33nayak@gmail.com